{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T21:41:14Z","timestamp":1793742074105,"version":"4.6.1"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,1,25]],"date-time":"2025-01-25T00:00:00Z","timestamp":1737763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,25]],"date-time":"2025-01-25T00:00:00Z","timestamp":1737763200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rev Endocr Metab Disord"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1007\/s11154-025-09944-x","type":"journal-article","created":{"date-parts":[[2025,1,25]],"date-time":"2025-01-25T08:46:31Z","timestamp":1737794791000},"page":"137-146","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Pituitary adenomas: biology, nomenclature and clinical classification"],"prefix":"10.1007","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2508-9588","authenticated-orcid":false,"given":"Ken K. Y.","family":"Ho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2355-3447","authenticated-orcid":false,"given":"Shlomo","family":"Melmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,25]]},"reference":[{"issue":"6","key":"9944_CR1","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1007\/s11102-019-00988-2","volume":"22","author":"KKY Ho","year":"2019","unstructured":"Ho KKY, Fleseriu M, Wass J, van der Lely A, Barkan A, Giustina A, et al. A tale of pituitary adenomas: to NET or not to NET\u202f: Pituitary Society position statement. Pituitary. 2019;22(6):569\u201373.","journal-title":"Pituitary"},{"issue":"6","key":"9944_CR2","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1210\/endrev\/bnac010","volume":"43","author":"S Melmed","year":"2022","unstructured":"Melmed S, Kaiser UB, Lopes MB, Bertherat J, Syro LV, Raverot G, et al. Clinical biology of the pituitary adenoma. Endocr Rev. 2022;43(6):1003\u201337.","journal-title":"Endocr Rev"},{"issue":"1","key":"9944_CR3","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/s12022-022-09703-7","volume":"33","author":"SL Asa","year":"2022","unstructured":"Asa SL, Mete O, Perry A, Osamura RY. Overview of the 2022 WHO Classification of Pituitary Tumors. Endocr Pathol. 2022;33(1):6\u201326.","journal-title":"Endocr Pathol."},{"key":"9944_CR4","doi-asserted-by":"crossref","unstructured":"Ho K, Fleseriu M, Kaiser U, Salvatori R, Brue T, Lopes MB, et al. Pituitary neoplasm nomenclature workshop: does adenoma stand the test of time? J Endocr Soc. 2021;5(3):bvaa205.","DOI":"10.1210\/jendso\/bvaa205"},{"issue":"11","key":"9944_CR5","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/s41574-023-00883-8","volume":"19","author":"KKY Ho","year":"2023","unstructured":"Ho KKY, Kaiser UB, Chanson P, Gadelha M, Wass J, Nieman L, et al. Pituitary adenoma or neuroendocrine tumour: the need for an integrated prognostic classification. Nat Rev Endocrinol. 2023;19(11):671\u20138.","journal-title":"Nat Rev Endocrinol"},{"issue":"3","key":"9944_CR6","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/S2213-8587(23)00382-0","volume":"12","author":"KKY Ho","year":"2024","unstructured":"Ho KKY, Fleseriu M, Wass J, Katznelson L, Raverot G, Little AS, et al. A proposed clinical classification for pituitary neoplasms to guide therapy and prognosis. Lancet Diabetes Endocrinol. 2024;12(3):209\u201314.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"9944_CR7","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/B978-0-444-59602-4.00012-5","volume":"124","author":"ME Molitch","year":"2014","unstructured":"Molitch ME. Nonfunctioning pituitary tumors. Handb Clin Neurol. 2014;124:167\u201384.","journal-title":"Handb Clin Neurol"},{"issue":"4","key":"9944_CR8","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1007\/s11102-012-0454-0","volume":"16","author":"M Gruppetta","year":"2013","unstructured":"Gruppetta M, Mercieca C, Vassallo J. Prevalence and incidence of pituitary adenomas: a population based study in Malta. Pituitary. 2013;16(4):545\u201353.","journal-title":"Pituitary"},{"issue":"4","key":"9944_CR9","first-page":"675","volume":"15","author":"BW Chong","year":"1994","unstructured":"Chong BW, Kucharczyk W, Singer W, George S. Pituitary gland MR: a comparative study of healthy volunteers and patients with microadenomas. AJNR Am J Neuroradiol. 1994;15(4):675\u20139.","journal-title":"AJNR Am J Neuroradiol"},{"issue":"9","key":"9944_CR10","doi-asserted-by":"publisher","first-page":"4268","DOI":"10.1210\/jc.2010-0537","volume":"95","author":"A Raappana","year":"2010","unstructured":"Raappana A, Koivukangas J, Ebeling T, Pirila T. Incidence of pituitary adenomas in Northern Finland in 1992\u20132007. J Clin Endocrinol Metab. 2010;95(9):4268\u201375.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"9944_CR11","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1530\/EJE-14-0144","volume":"171","author":"A Tjornstrand","year":"2014","unstructured":"Tjornstrand A, Gunnarsson K, Evert M, Holmberg E, Ragnarsson O, Rosen T, et al. The incidence rate of pituitary adenomas in western Sweden for the period 2001\u20132011. Eur J Endocrinol. 2014;171(4):519\u201326.","journal-title":"Eur J Endocrinol"},{"issue":"12","key":"9944_CR12","doi-asserted-by":"publisher","first-page":"4769","DOI":"10.1210\/jc.2006-1668","volume":"91","author":"AF Daly","year":"2006","unstructured":"Daly AF, Rixhon M, Adam C, Dempegioti A, Tichomirowa MA, Beckers A. High prevalence of pituitary adenomas: a cross-sectional study in the province of Liege Belgium. J Clin Endocrinol Metab. 2006;91(12):4769\u201375.","journal-title":"J Clin Endocrinol Metab"},{"issue":"223","key":"9944_CR13","first-page":"2172","volume":"5","author":"E Fontana","year":"2009","unstructured":"Fontana E, Gaillard R. Epidemiology of pituitary adenoma: results of the first Swiss study. Rev Med Suisse. 2009;5(223):2172\u20134.","journal-title":"Rev Med Suisse"},{"issue":"3","key":"9944_CR14","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1111\/j.1365-2265.2009.03667.x","volume":"72","author":"A Fernandez","year":"2010","unstructured":"Fernandez A, Karavitaki N, Wass JA. Prevalence of pituitary adenomas: a community-based, cross-sectional study in Banbury (Oxfordshire, UK). Clin Endocrinol (Oxf). 2010;72(3):377\u201382.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"5","key":"9944_CR15","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1530\/EJE-15-0189","volume":"173","author":"TT Agustsson","year":"2015","unstructured":"Agustsson TT, Baldvinsdottir T, Jonasson JG, Olafsdottir E, Steinthorsdottir V, Sigurdsson G, et al. The epidemiology of pituitary adenomas in Iceland, 1955\u20132012: a nationwide population-based study. Eur J Endocrinol. 2015;173(5):655\u201364.","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"9944_CR16","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1007\/s11102-019-01027-w","volume":"23","author":"KKY Ho","year":"2020","unstructured":"Ho KKY, Fleseriu M, Wass J, van der Lely A, Barkan A, Giustina A, et al. The tale in evolution: clarity, consistency and consultation, not contradiction and confusion. Pituitary. 2020;23(4):476\u20137.","journal-title":"Pituitary"},{"issue":"2","key":"9944_CR17","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s11154-020-09556-7","volume":"21","author":"OM Dekkers","year":"2020","unstructured":"Dekkers OM, Karavitaki N, Pereira AM. The epidemiology of aggressive pituitary tumors (and its challenges). Rev Endocr Metab Disord. 2020;21(2):209\u201312.","journal-title":"Rev Endocr Metab Disord"},{"issue":"2","key":"9944_CR18","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1530\/eje.1.02326","volume":"156","author":"W Saeger","year":"2007","unstructured":"Saeger W, Ludecke DK, Buchfelder M, Fahlbusch R, Quabbe HJ, Petersenn S. Pathohistological classification of pituitary tumors: 10 years of experience with the German pituitary tumor registry. Eur J Endocrinol. 2007;156(2):203\u201316.","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"9944_CR19","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s00401-013-1084-y","volume":"126","author":"J Trouillas","year":"2013","unstructured":"Trouillas J, Roy P, Sturm N, Dantony E, Cortet-Rudelli C, Viennet G, et al. A new prognostic clinicopathological classification of pituitary adenomas: a multicentric case-control study of 410 patients with 8 years post-operative follow-up. Acta Neuropathol. 2013;126(1):123\u201335.","journal-title":"Acta Neuropathol"},{"issue":"2","key":"9944_CR20","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1007\/s12022-019-9568-5","volume":"30","author":"OM Alshaikh","year":"2019","unstructured":"Alshaikh OM, Asa SL, Mete O, Ezzat S. An institutional experience of tumor progression to pituitary carcinoma in a 15-Year cohort of 1055 consecutive pituitary neuroendocrine tumors. Endocr Pathol. 2019;30(2):118\u201327.","journal-title":"Endocr Pathol"},{"issue":"4","key":"9944_CR21","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1002\/(SICI)1097-0142(19970215)79:4<804::AID-CNCR18>3.0.CO;2-3","volume":"79","author":"PJ Pernicone","year":"1997","unstructured":"Pernicone PJ, Scheithauer BW, Sebo TJ, Kovacs KT, Horvath E, Young WF Jr, et al. Pituitary carcinoma: a clinicopathologic study of 15 cases. Cancer. 1997;79(4):804\u201312.","journal-title":"Cancer"},{"issue":"Suppl 1","key":"9944_CR22","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1159\/000080731","volume":"80","author":"BG Taal","year":"2004","unstructured":"Taal BG, Visser O. Epidemiology of neuroendocrine tumours. Neuroendocrinology. 2004;80(Suppl 1):3\u20137.","journal-title":"Neuroendocrinology"},{"issue":"4","key":"9944_CR23","doi-asserted-by":"publisher","first-page":"C5","DOI":"10.1530\/ERC-17-0004","volume":"24","author":"SL Asa","year":"2017","unstructured":"Asa SL, Casar-Borota O, Chanson P, Delgrange E, Earls P, Ezzat S, et al. From pituitary adenoma to pituitary neuroendocrine tumor (PitNET): an international pituitary pathology club proposal. Endocr Relat Cancer. 2017;24(4):C5\u20138.","journal-title":"Endocr Relat Cancer"},{"issue":"2","key":"9944_CR24","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1353\/pbm.2011.0015","volume":"54","author":"A Jutel","year":"2011","unstructured":"Jutel A. Classification, disease, and diagnosis. Perspect Biol Med. 2011;54(2):189\u2013205.","journal-title":"Perspect Biol Med"},{"key":"9944_CR25","doi-asserted-by":"crossref","unstructured":"Doust JA, Bell KJL, Glasziou PP. Potential consequences of changing disease classifications. JAMA. 2020;323(10):921\u20132.","DOI":"10.1001\/jama.2019.22373"},{"issue":"7","key":"9944_CR26","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1001\/jamainternmed.2017.1302","volume":"177","author":"J Doust","year":"2017","unstructured":"Doust J, Vandvik PO, Qaseem A, Mustafa RA, Horvath AR, Frances A, et al. Guidance for modifying the definition of diseases: a checklist. JAMA Intern Med. 2017;177(7):1020\u20135.","journal-title":"JAMA Intern Med"},{"issue":"10","key":"9944_CR27","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1001\/jamaoncol.2017.0589","volume":"3","author":"A Dasari","year":"2017","unstructured":"Dasari A, Shen C, Halperin D, Zhao B, Zhou S, Xu Y, et al. Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States. JAMA Oncol. 2017;3(10):1335\u201342.","journal-title":"JAMA Oncol"},{"issue":"1","key":"9944_CR28","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s12022-022-09708-2","volume":"33","author":"G Rindi","year":"2022","unstructured":"Rindi G, Mete O, Uccella S, Basturk O, La Rosa S, Brosens LAA, et al. Overview of the 2022 WHO classification of neuroendocrine neoplasms. Endocr Pathol. 2022;33(1):115\u201354.","journal-title":"Endocr Pathol"},{"issue":"6","key":"9944_CR29","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1001\/jamaoncol.2019.0054","volume":"5","author":"PR Dixon","year":"2019","unstructured":"Dixon PR, Tomlinson G, Pasternak JD, Mete O, Bell CM, Sawka AM, et al. The role of disease label in patient perceptions and treatment decisions in the setting of low-risk malignant neoplasms. JAMA Oncol. 2019;5(6):817\u201323.","journal-title":"JAMA Oncol"},{"issue":"2","key":"9944_CR30","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1017\/S0022215105004688","volume":"120","author":"NK Chadha","year":"2006","unstructured":"Chadha NK, Repanos C. Patients\u2019 understanding of words used to describe lumps: a cross-sectional study. J Laryngol Otol. 2006;120(2):125\u20138.","journal-title":"J Laryngol Otol"},{"issue":"2","key":"9944_CR31","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1093\/fampra\/cmv008","volume":"32","author":"A Van den Bruel","year":"2015","unstructured":"Van den Bruel A. The triumph of medicine: how overdiagnosis is turning healthy people into patients. Fam Pract. 2015;32(2):127\u20138.","journal-title":"Fam Pract"},{"issue":"4","key":"9944_CR32","doi-asserted-by":"publisher","first-page":"189","DOI":"10.5694\/mja2.50578","volume":"213","author":"PP Glasziou","year":"2020","unstructured":"Glasziou PP, Bell KJ, Barratt AL. Estimating the magnitude of cancer overdiagnosis in Australia. Med J Aust. 2020;213(4):189-e1.","journal-title":"Med J Aust"},{"key":"9944_CR33","doi-asserted-by":"publisher","first-page":"154","DOI":"10.17849\/insm-50-2-154-156.1","volume":"50","author":"T Meagher","year":"2024","unstructured":"Meagher T. From benign to malignant: the arrival of pituitary neuroendocrine tumors (PitNETs). J Insur Med. 2024;50:154\u20136.","journal-title":"J Insur Med"},{"key":"9944_CR34","unstructured":"Brat D, Gill A, Wesseling P et al. Tumours of the sellar region. Central Nervous System Tumours WHO Classification of Tumours 6. 5 ed: International Agency for Research on Cancer; 2021."},{"key":"9944_CR35","doi-asserted-by":"crossref","unstructured":"Ho KKY, Melmed S. Letter to the Editor from Ho and Melmed: clinical practice and nomenclature of pituitary neoplasms: common sense must prevail. J Clin Endocrinol Metab. 2024.","DOI":"10.1210\/clinem\/dgae332"},{"issue":"5","key":"9944_CR36","doi-asserted-by":"publisher","first-page":"e1408","DOI":"10.1210\/clinem\/dgad567","volume":"109","author":"PM Stewart","year":"2024","unstructured":"Stewart PM. Clinical practice and nomenclature of pituitary neoplasms: common sense must prevail. J Clin Endocrinol Metab. 2024;109(5):e1408\u20139.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3 Suppl 29","key":"9944_CR37","first-page":"S42","volume":"21","author":"TA Medsger Jr","year":"2003","unstructured":"Medsger TA Jr, Bombardieri S, Czirjak L, Scorza R, Della Rossa A, Bencivelli W. Assessment of disease severity and prognosis. Clin Exp Rheumatol. 2003;21(3 Suppl 29):S42-6.","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"9944_CR38","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1210\/jc.2007-1191","volume":"93","author":"OM Dekkers","year":"2008","unstructured":"Dekkers OM, Biermasz NR, Pereira AM, Romijn JA, Vandenbroucke JP. Mortality in acromegaly: a metaanalysis. J Clin Endocrinol Metab. 2008;93(1):61\u20137.","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"9944_CR39","doi-asserted-by":"publisher","first-page":"R67","DOI":"10.1530\/EJE-19-1023","volume":"182","author":"NF Lenders","year":"2020","unstructured":"Lenders NF, McCormack AI, Ho KKY. Management of endocrine disease: does gender matter in the management of acromegaly? Eur J Endocrinol. 2020;182(5):R67\u201382.","journal-title":"Eur J Endocrinol"},{"issue":"11","key":"9944_CR40","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1016\/S2213-8587(22)00244-3","volume":"10","author":"M Fleseriu","year":"2022","unstructured":"Fleseriu M, Langlois F, Lim DST, Varlamov EV, Melmed S. Acromegaly: pathogenesis, diagnosis, and management. Lancet Diabetes Endocrinol. 2022;10(11):804\u201326.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"7","key":"9944_CR41","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/S2213-8587(16)30005-5","volume":"4","author":"RN Clayton","year":"2016","unstructured":"Clayton RN, Jones PW, Reulen RC, Stewart PM, Hassan-Smith ZK, Ntali G, et al. Mortality in patients with Cushing\u2019s disease more than 10 years after remission: a multicentre, multinational, retrospective cohort study. Lancet Diabetes Endocrinol. 2016;4(7):569\u201376.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"6","key":"9944_CR42","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1210\/jc.2018-02524","volume":"104","author":"O Ragnarsson","year":"2019","unstructured":"Ragnarsson O, Olsson DS, Papakokkinou E, Chantzichristos D, Dahlqvist P, Segerstedt E, et al. Overall and disease-specific mortality in patients with cushing disease: a Swedish nationwide study. J Clin Endocrinol Metab. 2019;104(6):2375\u201384.","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"9944_CR43","doi-asserted-by":"publisher","first-page":"2377","DOI":"10.1210\/clinem\/dgac265","volume":"107","author":"P Limumpornpetch","year":"2022","unstructured":"Limumpornpetch P, Morgan AW, Tiganescu A, Baxter PD, Nyawira Nyaga V, Pujades-Rodriguez M, et al. The effect of endogenous cushing syndrome on all-cause and cause-specific mortality. J Clin Endocrinol Metab. 2022;107(8):2377\u201388.","journal-title":"J Clin Endocrinol Metab"},{"key":"9944_CR44","doi-asserted-by":"crossref","unstructured":"Petersenn S, Fleseriu M, Casanueva FF, Giustina A, Biermasz N, Biller BMK et al. Diagnosis and management of prolactin-secreting pituitary adenomas: a Pituitary Society international consensus statement. Nat Rev Endocrinol. 2023.","DOI":"10.1038\/s41574-023-00886-5"},{"issue":"8","key":"9944_CR45","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1530\/EC-17-0171","volume":"6","author":"E Soto-Pedre","year":"2017","unstructured":"Soto-Pedre E, Newey PJ, Bevan JS, Leese GP. Morbidity and mortality in patients with hyperprolactinaemia: the PROLEARS study. Endocr Connect. 2017;6(8):580\u20138.","journal-title":"Endocr Connect"},{"issue":"4","key":"9944_CR46","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1210\/jc.2010-1054","volume":"96","author":"MM Fernandez-Balsells","year":"2011","unstructured":"Fernandez-Balsells MM, Murad MH, Barwise A, Gallegos-Orozco JF, Paul A, Lane MA, et al. Natural history of nonfunctioning pituitary adenomas and incidentalomas: a systematic review and metaanalysis. J Clin Endocrinol Metab. 2011;96(4):905\u201312.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"9944_CR47","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1007\/s11154-020-09588-z","volume":"21","author":"A Giustina","year":"2020","unstructured":"Giustina A, Barkhoudarian G, Beckers A, Ben-Shlomo A, Biermasz N, Biller B, et al. Multidisciplinary management of acromegaly: a consensus. Rev Endocr Metab Disord. 2020;21(4):667\u201378.","journal-title":"Rev Endocr Metab Disord"},{"issue":"4","key":"9944_CR48","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1210\/jc.2014-3787","volume":"100","author":"JM Pappachan","year":"2015","unstructured":"Pappachan JM, Raskauskiene D, Kutty VR, Clayton RN. Excess mortality associated with hypopituitarism in adults: a meta-analysis of observational studies. J Clin Endocrinol Metab. 2015;100(4):1405\u201311.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"9944_CR49","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1210\/er.2009-0033","volume":"31","author":"M Sherlock","year":"2010","unstructured":"Sherlock M, Ayuk J, Tomlinson JW, Toogood AA, Aragon-Alonso A, Sheppard MC, et al. Mortality in patients with pituitary disease. Endocr Rev. 2010;31(3):301\u201342.","journal-title":"Endocr Rev"},{"issue":"10274","key":"9944_CR50","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/S0140-6736(21)00136-7","volume":"397","author":"ES Husebye","year":"2021","unstructured":"Husebye ES, Pearce SH, Krone NP, Kampe O. Adrenal insufficiency. Lancet. 2021;397(10274):613\u201329.","journal-title":"Lancet"},{"issue":"1","key":"9944_CR51","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s12020-016-1159-3","volume":"56","author":"S Jasim","year":"2017","unstructured":"Jasim S, Alahdab F, Ahmed AT, Tamhane S, Prokop LJ, Nippoldt TB, et al. Mortality in adults with hypopituitarism: a systematic review and meta-analysis. Endocrine. 2017;56(1):33\u201342.","journal-title":"Endocrine"},{"issue":"10","key":"9944_CR52","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1056\/NEJMra1810772","volume":"382","author":"S Melmed","year":"2020","unstructured":"Melmed S. Pituitary-tumor endocrinopathies. N Engl J Med. 2020;382(10):937\u201350.","journal-title":"N Engl J Med"},{"issue":"5","key":"9944_CR53","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1001\/jama.2016.19699","volume":"317","author":"ME Molitch","year":"2017","unstructured":"Molitch ME. Diagnosis and treatment of pituitary adenomas: a review. JAMA. 2017;317(5):516\u201324.","journal-title":"JAMA"},{"issue":"9","key":"9944_CR54","doi-asserted-by":"publisher","first-page":"3368","DOI":"10.1210\/jc.2017-00773","volume":"102","author":"G Raverot","year":"2017","unstructured":"Raverot G, Dantony E, Beauvy J, Vasiljevic A, Mikolasek S, Borson-Chazot F, et al. Risk of recurrence in pituitary neuroendocrine tumors: a prospective study using a five-tiered classification. J Clin Endocrinol Metab. 2017;102(9):3368\u201374.","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"9944_CR55","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1530\/EJE-22-0812","volume":"187","author":"N Sahakian","year":"2022","unstructured":"Sahakian N, Appay R, Resseguier N, Graillon T, Piazzola C, Laure C, et al. Real-life clinical impact of a five-tiered classification of pituitary tumors. Eur J Endocrinol. 2022;187(6):893\u2013904.","journal-title":"Eur J Endocrinol"},{"key":"9944_CR56","doi-asserted-by":"publisher","first-page":"879702","DOI":"10.3389\/fendo.2022.879702","volume":"13","author":"Y Chen","year":"2022","unstructured":"Chen Y, Xu X, Cao J, Jie Y, Wang L, Cai F, et al. Transsphenoidal surgery of giant pituitary adenoma: results and experience of 239 cases in a single center. Front Endocrinol (Lausanne). 2022;13:879702.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"9944_CR57","doi-asserted-by":"crossref","unstructured":"Knosp E, Steiner E, Kitz K, Matula C. Pituitary adenomas with invasion of the cavernous sinus space: a magnetic resonance imaging classification compared with surgical findings. Neurosurgery. 1993;33(4):610\u20137; discussion 7\u20138.","DOI":"10.1227\/00006123-199310000-00008"},{"issue":"3","key":"9944_CR58","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ando.2015.04.003","volume":"76","author":"C Cortet-Rudelli","year":"2015","unstructured":"Cortet-Rudelli C, Bonneville JF, Borson-Chazot F, Clavier L, Coche Dequeant B, Desailloud R, et al. Post-surgical management of non-functioning pituitary adenoma. Ann Endocrinol. 2015;76(3):228\u201338.","journal-title":"Ann Endocrinol"},{"issue":"10","key":"9944_CR59","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1210\/js.2019-00163","volume":"3","author":"J Maletkovic","year":"2019","unstructured":"Maletkovic J, Dabbagh A, Zhang D, Zahid A, Bergsneider M, Wang MB, et al. Residual tumor confers a 10-Fold Increased risk of regrowth in clinically nonfunctioning pituitary tumors. J Endocr Soc. 2019;3(10):1931\u201341.","journal-title":"J Endocr Soc"},{"issue":"1","key":"9944_CR60","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/s12022-022-09703-7","volume":"33","author":"SL Asa","year":"2022","unstructured":"Asa SL, Mete O, Perry A, Osamura RY. Overview of the 2022 WHO classification of pituitary tumors. Endocr Pathol. 2022;33(1):6\u201326.","journal-title":"Endocr Pathol"},{"issue":"4","key":"9944_CR61","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1530\/EJE-22-0440","volume":"187","author":"P Burman","year":"2022","unstructured":"Burman P, Trouillas J, Losa M, McCormack A, Petersenn S, Popovic V, et al. Aggressive pituitary tumours and carcinomas, characteristics and management of 171 patients. Eur J Endocrinol. 2022;187(4):593\u2013605.","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"9944_CR62","doi-asserted-by":"publisher","first-page":"R235","DOI":"10.1530\/EJE-19-0602","volume":"181","author":"S Vandeva","year":"2019","unstructured":"Vandeva S, Daly AF, Petrossians P, Zacharieva S, Beckers A. Somatic and germline mutations in the pathogenesis of pituitary adenomas. Eur J Endocrinol. 2019;181(6):R235\u201354.","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"9944_CR63","doi-asserted-by":"publisher","first-page":"R21","DOI":"10.1530\/JOE-18-0446","volume":"240","author":"S Pepe","year":"2019","unstructured":"Pepe S, Korbonits M, Iacovazzo D. Germline and mosaic mutations causing pituitary tumours: genetic and molecular aspects. J Endocrinol. 2019;240(2):R21-r45.","journal-title":"J Endocrinol"},{"issue":"3","key":"9944_CR64","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1530\/EJE-15-1064","volume":"174","author":"CL Ronchi","year":"2016","unstructured":"Ronchi CL, Peverelli E, Herterich S, Weigand I, Mantovani G, Schwarzmayr T, et al. Landscape of somatic mutations in sporadic GH-secreting pituitary adenomas. Eur J Endocrinol. 2016;174(3):363\u201372.","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"9944_CR65","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/ng.3166","volume":"47","author":"M Reincke","year":"2015","unstructured":"Reincke M, Sbiera S, Hayakawa A, Theodoropoulou M, Osswald A, Beuschlein F, et al. Mutations in the deubiquitinase gene USP8 cause Cushing\u2019s disease. Nat Genet. 2015;47(1):31\u20138.","journal-title":"Nat Genet"},{"issue":"11","key":"9944_CR66","doi-asserted-by":"publisher","first-page":"5738","DOI":"10.1172\/JCI138540","volume":"130","author":"A Ben-Shlomo","year":"2020","unstructured":"Ben-Shlomo A, Deng N, Ding E, Yamamoto M, Mamelak A, Chesnokova V, et al. DNA damage and growth hormone hypersecretion in pituitary somatotroph adenomas. J Clin Invest. 2020;130(11):5738\u201355.","journal-title":"J Clin Invest"},{"issue":"7","key":"9944_CR67","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1210\/en.2016-1967","volume":"158","author":"WL Bi","year":"2017","unstructured":"Bi WL, Greenwald NF, Ramkissoon SH, Abedalthagafi M, Coy SM, Ligon KL, et al. Clinical identification of oncogenic drivers and copy-number alterations in pituitary tumors. Endocrinology. 2017;158(7):2284\u201391.","journal-title":"Endocrinology"},{"key":"9944_CR68","doi-asserted-by":"crossref","unstructured":"Neou M, Villa C, Armignacco R, Jouinot A, Raffin-Sanson ML, Septier A et al. Pangenomic classification of pituitary neuroendocrine tumors. Cancer Cell. 2020;37(1):123\u201334 e5.","DOI":"10.1016\/j.ccell.2019.11.002"}],"container-title":["Reviews in Endocrine and Metabolic Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11154-025-09944-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11154-025-09944-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11154-025-09944-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T05:38:58Z","timestamp":1742276338000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11154-025-09944-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,25]]},"references-count":68,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["9944"],"URL":"https:\/\/doi.org\/10.1007\/s11154-025-09944-x","relation":{},"ISSN":["1389-9155","1573-2606"],"issn-type":[{"value":"1389-9155","type":"print"},{"value":"1573-2606","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,25]]},"assertion":[{"value":"13 January 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}